Feasibility and Effectiveness of a Psychosis-Specific Intensive Outpatient Program - PubMed (original) (raw)

Feasibility and Effectiveness of a Psychosis-Specific Intensive Outpatient Program

Erin Samplin et al. Psychiatr Res Clin Pract. 2022.

Abstract

Objective: Intensive outpatient programs (IOPs) are rarely designed specifically to treat psychosis. In 2016 UCLA established the Thought Disorders Intensive Outpatient Program (TD IOP), combining a time-limited, group-based intervention called cognitive behavioral social skills training (CBSST) and medication management to treat individuals with psychosis. The purpose of this study is to assess the feasibility of developing an IOP for individuals with psychosis and the effectiveness of the program in improving psychotic symptom severity.

Methods: Adults were referred to the TD IOP from inpatient and outpatient settings. Programming included 3 hours of CBSST and 6 hours of additional groups weekly as well as individual psychiatry and social work services. Primary outcomes were symptom changes as measured at intake and discharge by the Clinician-Rated Dimensions of Psychosis Symptom Severity scale. Program feedback was solicited from a small subset of patients.

Results: Of the 92 enrolled subjects, 71 completed the program (77.2%). Average length of stay was 52 ± 30 days across all enrolled. Participants showed significant (p < 0.05) improvement with small-moderate effect sizes across five of eight psychosis symptom domains (hallucinations, delusions, disorganized speech, depression, and mania). Patient-reported program satisfaction was high (86.6 ± 12.7 score, range 0-100).

Conclusions: The current study indicates that targeted treatment for psychosis is successful within an IOP framework, with minimal additional training required for Master's level clinicians. Participants demonstrated significant symptomatic relief from group-based, time-limited treatment. Further work is needed to determine the full range of program benefits on patient well-being and illness morbidity.

© 2022 The Authors. Psychiatric Research and Clinical Practice published by Wiley Periodicals, LLC on behalf of American Psychiatric Association.

PubMed Disclaimer

References

    1. Mander H, Kingdon D: The evolution of cognitive‐behavioral therapy for psychosis. Psychol Res Behav Manag. 2015; 8:63–9 -PMC -PubMed
    1. Wykes T, Steel C, Everitt B, Tarrier N: Cognitive behavior therapy for schizophrenia: effect sizes, clinical models, and methodological rigor. Schizophr Bull. 2008; 34(3):523–37. 10.1093/schbul/sbm114 -DOI -PMC -PubMed
    1. Kreyenbuhl J, Buchanan RW, Dickerson FB, Dixon LB: The schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2009. Schizophr Bull. 2010; 36(1):94–103. 10.1093/schbul/sbp130 -DOI -PMC -PubMed
    1. Gould RA, Mueser KT, Bolton E, Mays V, Goff D: Cognitive therapy for psychosis in schizophrenia: an effect size analysis. Schizophr Res. 2001; 48(2–3):335–42. 10.1016/s0920-9964(00)00145-6 -DOI -PubMed
    1. Rector NA, Seeman MV, Segal ZV: Cognitive therapy for schizophrenia: a preliminary randomized controlled trial. Schizophr Res. 2003; 63(1–2):1–11. 10.1016/s0920-9964(02)00308-0 -DOI -PubMed

LinkOut - more resources